Keenova Therapeutics and Par Health
A Manager, Controlled Substances Compliance at Par Health oversees the implementation and enhancement of internal controlled substances analytics and compliance programs. This role is central to the company's Anti-Diversion Program, focusing on detecting and preventing diversion and abuse of controlled substances through regulatory compliance and data analysis.
Keenova Therapeutics and Par Health are the successor entities formed after Mallinckrodt's merger with Endo; Keenova Therapeutics focuses on specialty therapeutics across rare and unaddressed conditions (immunology, urology, hepatology, ophthalmology, orthopedics, critical care), while Par Health develops high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs) with a robust U.S.-advantaged manufacturing network.
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Aug 1, 2025
With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health
Nov 11, 2025
Judge Says 'Error' Kept Mallinckrodt Execs In Investor Suit
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Keenova Therapeutics and Par Health.
Keenova Therapeutics and Par Health didn’t post a salary, so this is our estimate from similar listings.
Mallinckrodt Names Christiana Stamoulis President and CFO
Aug 6, 2025
Specialist, Controlled Substances Compliance - Analyst
Par Health
DEA Compliance Auditor
1080030P
Senior Manager Controlled Substances
Animal Health International
Advisor – Quality Audit and Compliance (Controlled Substances)
Eli Lilly and Company
QA Compliance Specialist - Controlled Substances
McKesson
Controlled Substance Program Supervisor
oraclecloudinfrastructure